PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.24, for a total value of $8,411,884.16. Following the completion of the transaction, the chief executive officer owned 53,954,101 shares in the company, valued at $2,710,654,034.24. The trade was a 0.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Tuesday, November 3rd, Jason Murray sold 26,504 shares of PACS Group stock. The shares were sold at an average price of $46.50, for a total value of $1,232,436.00.
- On Monday, November 2nd, Jason Murray sold 31,358 shares of PACS Group stock. The shares were sold at an average price of $46.02, for a total value of $1,443,095.16.
- On Thursday, October 29th, Jason Murray sold 1,904 shares of PACS Group stock. The shares were sold at an average price of $50.05, for a total value of $95,295.20.
- On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total value of $345,639.90.
- On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total value of $3,349,366.20.
- On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The stock was sold at an average price of $47.55, for a total value of $651,244.80.
- On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total value of $314,768.20.
- On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total transaction of $1,785,779.05.
- On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40.
- On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total transaction of $402,875.82.
PACS Group Trading Up 8.5%
Shares of PACS Group stock traded up $3.95 during trading on Wednesday, hitting $50.63. The stock had a trading volume of 1,790,293 shares, compared to its average volume of 895,995. The stock has a 50 day simple moving average of $44.29 and a 200 day simple moving average of $39.85. The company has a market capitalization of $8.01 billion, a PE ratio of 29.44, a P/E/G ratio of 1.42 and a beta of -0.14. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. PACS Group, Inc. has a 1 year low of $10.31 and a 1 year high of $51.68.
PACS Group (NYSE:PACS – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. On average, research analysts expect that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.
Key Stories Impacting PACS Group
Here are the key news stories impacting PACS Group this week:
- Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
- Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing
Institutional Trading of PACS Group
Several institutional investors have recently made changes to their positions in PACS. Dimensional Fund Advisors LP increased its stake in PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after buying an additional 614,250 shares during the period. Sei Investments Co. lifted its position in PACS Group by 7.4% in the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock worth $11,900,000 after buying an additional 25,462 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of PACS Group by 44.6% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after buying an additional 89,067 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of PACS Group during the 2nd quarter valued at $8,196,000. Finally, Corient Private Wealth LP boosted its stake in shares of PACS Group by 1.8% during the 2nd quarter. Corient Private Wealth LP now owns 152,846 shares of the company’s stock valued at $6,517,000 after buying an additional 2,680 shares during the period.
Analysts Set New Price Targets
Several brokerages have issued reports on PACS. UBS Group boosted their target price on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Zacks Research cut PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Royal Bank Of Canada lifted their price target on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Finally, JPMorgan Chase & Co. upped their price target on PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $58.80.
Read Our Latest Stock Report on PACS
PACS Group Company Profile
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Featured Articles
- Five stocks we like better than PACS Group
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
